CliffBio
small molecule

PRAMIPEXOLE DIHYDROCHLORIDE

PRAMIPEXOLE DIHYDROCHLORIDE

Loss of exclusivity—loss of exclusivity
CompanyAlembic →See this company's full patent-cliff portfolio

Drug detail

Brand namePRAMIPEXOLE DIHYDROCHLORIDE
Active ingredientPRAMIPEXOLE DIHYDROCHLORIDE
Strength2.25MG
Dosage formTABLET, EXTENDED RELEASE
RouteORAL
ModalitySmall molecule
FDA approvalJanuary 2019
Marketing statusRX

More from Alembic

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.